Skip to content

Caffeine treatment for stimulation of spontaneous breathing in preterm infants at birth

Caffeine treatment for stimulation of spontaneous breathing in preterm infants at birth - CAffeine for Breathing At Birth

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41183
Enrollment
26
Registered
2014-10-23
Start date
2014-11-03
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

improvement of breathing of neonates Respiratory function due to caffeine treatment

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Preterm infants born

Exclusion criteria

Exclusion criteria: Congenital abnormalities or condition that might have an adverse effect on breathing or ventilation, including: congenital diaphragmatic hernia, trachea-esophageal fistula or cyanotic heart disease.

Design outcomes

Primary

MeasureTime frame
- Average respiratory minute volume at 7-10 minutes after birth

Secondary

MeasureTime frame
- Average Rate of rise to maximum tidal volume at 7-10 minutes after birth - Time of mask ventilation given - Oxygen saturation and heart rate in the first 10 minutes from birth - Maximal oxygen needed in the first 10 minutes - Total amount of pure oxygen given to the patient (oxygen load) will be calculated taking into consideration birth weight, tidal volume, respiratory rate, fraction of inspired oxygen and timing of stabilisation

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)